Carson Wealth (CWM LLC)’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $424K | Sell |
47,335
-6,415
| -12% | -$57.5K | ﹤0.01% | 1663 |
|
|
2025
Q1 | $403K | Buy |
53,750
+33,656
| +167% | +$252K | ﹤0.01% | 1540 |
|
|
2024
Q4 | $151K | Buy |
20,094
+3,022
| +18% | +$22.7K | ﹤0.01% | 2011 |
|
|
2024
Q3 | $130K | Buy |
17,072
+11,414
| +202% | +$86.9K | ﹤0.01% | 2017 |
|
|
2024
Q2 | $35K | Buy |
5,658
+3,772
| +200% | +$23.3K | ﹤0.01% | 2712 |
|
|
2024
Q1 | $10K | Buy |
1,886
+322
| +21% | +$1.71K | ﹤0.01% | 3310 |
|
|
2023
Q4 | $9K | Sell |
1,564
-1,967
| -56% | -$11.3K | ﹤0.01% | 3222 |
|
|
2023
Q3 | $25K | Buy |
3,531
+18
| +0.5% | +$127 | ﹤0.01% | 2516 |
|
|
2023
Q2 | $25K | Sell |
3,513
-42
| -1% | -$299 | ﹤0.01% | 2468 |
|
|
2023
Q1 | $30K | Sell |
3,555
-73
| -2% | -$616 | ﹤0.01% | 2215 |
|
|
2022
Q4 | $42K | Buy |
3,628
+215
| +6% | +$2.49K | ﹤0.01% | 1836 |
|
|
2022
Q3 | $43K | Hold |
3,413
| – | – | ﹤0.01% | 1725 |
|
|
2022
Q2 | $36K | Hold |
3,413
| – | – | ﹤0.01% | 1774 |
|
|
2022
Q1 | $55K | Hold |
3,413
| – | – | ﹤0.01% | 1557 |
|
|
2021
Q4 | $47K | Buy |
+3,413
| New | +$47K | ﹤0.01% | 1590 |
|
|
2021
Q2 | $54K | Hold |
3,413
| – | – | ﹤0.01% | 1368 |
|
|
2021
Q1 | $54K | Hold |
3,413
| – | – | ﹤0.01% | 1368 |
|
|
2020
Q4 | $54K | Hold |
3,413
| – | – | ﹤0.01% | 1368 |
|
|
2020
Q3 | $54K | Hold |
3,413
| – | – | ﹤0.01% | 1368 |
|
|
2020
Q2 | $54K | Hold |
3,413
| – | – | ﹤0.01% | 1368 |
|
|
2020
Q1 | $54K | Hold |
3,413
| – | – | ﹤0.01% | 1368 |
|
|
2019
Q4 | $54K | Hold |
3,413
| – | – | ﹤0.01% | 1368 |
|
|
2019
Q3 | $54K | Hold |
3,413
| – | – | ﹤0.01% | 1368 |
|
|
2019
Q2 | $54K | Hold |
3,413
| – | – | ﹤0.01% | 1368 |
|
|
2019
Q1 | $54K | Buy |
+3,413
| New | +$54K | ﹤0.01% | 1368 |
|